ArriVent BioPharma, Inc. Common Stock Net Asset Momentum
ArriVent BioPharma, Inc. Common Stock net asset momentum. ArriVent BioPharma, Inc. Common Stock (AVBP) recorded a net asset momentum of 19.2% as of September 2025, with net assets of $307.22 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore AVBP cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of ArriVent BioPharma, Inc. Common Stock (2021–2025)
Net asset momentum of ArriVent BioPharma, Inc. Common Stock from 2021 to 2025. This chart tracks ArriVent BioPharma, Inc. Common Stock's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +19.2%, with net assets of $307.22 Million USD as of September 2025. See ArriVent BioPharma, Inc. Common Stock net assets for net asset value and shareholders' equity analysis.
ArriVent BioPharma, Inc. Common Stock Net Asset Momentum by Year (2021–2025)
ArriVent BioPharma, Inc. Common Stock net asset momentum by year from 2021 to 2025. The table below shows the complete annual net asset history for ArriVent BioPharma, Inc. Common Stock from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see ArriVent BioPharma, Inc. Common Stock (AVBP) market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $307.22 Million | $333.17 Million | $25.95 Million | ▲ +19.2% |
| 2024 | $257.65 Million | $274.94 Million | $17.29 Million | ▲ +70.3% |
| 2023 | $151.30 Million | $163.10 Million | $11.80 Million | ▼ -13.3% |
| 2022 | $174.46 Million | $182.83 Million | $8.37 Million | ▲ +323.2% |
| 2021 | $41.22 Million | $43.04 Million | $1.82 Million | — |